Neurologic complications of radiation therapy

Cancer Neurology In Clinical Practice: Neurologic Complications of Cancer and Its Treatment: Second Edition

Volumn , Issue , 2008, Pages 259-286

  Chi, Daisy ^a   Béhin, Anthony ^a   Delattre, Jean Yves ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

leukoencephalopathy; neurotoxicity; radiation; radiosurgery; stem cells

Indexed keywords

EID: 77649192447     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-412-4_16     Document Type: Chapter

References (250)

1. New P. Radiation injury to the nervous system Curr Opin Neurol. 2001; 14:725-734.
2. Swennen MH. Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma JNeurooncol. 2004; 66:333-339.
3. Belka C, Budach W, Kortmann RD et al. Radiation-induced CNS toxicity: molecular and cellular mechanisms Br J Cancer. 2001; 85:1233-1239.
4. Li YQ, Chen P, Haimovitz-Friedman A et al. Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation Cancer Res. 2003; 63:5950-5956.
5. Lyubimova N, Hopewell JW. Experimental evidence to support the hypothesis that damage to vascular endothelium plays the primary role in the development of late radiation-induced CNS injury Br J Radiol. 2004; 77:488-492.
6. Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: an update and review of the literature Acta Neuropathol (Berl). 2006; 111:197-212.
7. Lai R, Abrey LE, Rosenblum MK et al. Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study Neurology.2004; 62:451-56.
8. Coderre JA, Morris GM, Micca PL et al. Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival Radiat Res. 2006;166:495-503.
9. Tofilon PJ, Fike JR. The radioresponse of the central nervous system: a dynamic process Radiat Res. 2000; 153: 357-370.
10. Schultheiss TE, Kun LE, Ang KK et al. Radiation response of the central nervous system Int J Radiat Oncol Biol Phys. 1995; 31: 1093-1112.
11. Quarmby S, Kumar P, Kumar S. Radiation-induced normal tissue injury: role of adhesion molecules in leukocyte-endothelial cell interactions Int J Cancer. 1999; 82:385-395.
12. Eissner G, Kohlhuber F, Grell M et al. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin Blood. 1995; 86:4184-193.
13. Daigle JL, Hong JH, Chiang CS et al. The role of tumor necrosis factor signaling pathways in the response of murine brain to irradiation Cancer Res. 2001; 61:8859-8865.
14. Van der Maazen RWM, Berhagen I, Kleiboer BJ et al. Radiosensitivity of glial progenitor cells of the perinatal and adult rat optic nerve studied by an in vitro clonogenic assay Radiother Oncol. 1991; 20:258-264.
15. Van der Maazen RWM, Kleiboer BJ, Berhagen I et al. Irradiation in vitro discriminates between different 0-2A progenitor cell subpopulations in the perinatal central nervous system of rats Radiat Res. 1991; 128:64-72 [Abstract]
16. Van der Maazen RWM, Kleiboer BJ, Berhagen I et al. Repair capacity of adult rat glial progenitor cells determined by an in vitro clonogenic assay after in vitro or in vivo fractionated irradiation Int J Radiat Biol. 1993; 63:661-666.
17. Chow, BM., Li, YQ, Wong, CS. Radiation-induced apoptosis in the adult central nervous system is p53-dependent Cell Death Differ. 2000; 7:712-720.
18. Atkinson SL, Li YQ, Wong CS. Apoptosis and proliferation of oligodendrocyte progenitor cells in the irradiated rodent spinal cord Int J Radiat Oncol Biol Phys. 2005; 62:535-544.
19. Hornsey S, Myers R, Coultas PG et al. Turnover of proliferative cells in the spinal cord after X-irradiation and its relation to time-dependent repair of radiation damage Br J Radiol.1981; 54:1081-1085.
20. Enokido Y, Araki T, Tanaka K et al. Involvement of p53 in DNA strand break-induced apoptosis in postmitotic CNS neurons Eur J Neurosci. 1996; 8:1812-1821.
21. Gobbel GT, Bellinzona M, Vogt AR et al. Response of postmitotic neurons to X-irradiation: implications for the role of DNA damage in neuronal apoptosis J Neurosci. 1998; 18: 147-155.
22. Chiang CS, McBride WH, and Withers HR. Radiation-induced astrocytic and microglial responses in mouse brain Radiother Oncol. 1993; 29:60-68.
23. Thomas WE. Brain macrophages: evaluation of microglia and their function Brain Res Rev. 1992. B17:61-74.
24. Omuro AM. Delayed neurotoxicity in primary central nervous system lymphoma Arch Neurol. 2005; 62:1595-1600.
25. Hopewell JW and Cavanagh JB. Effects of X-irradiation on the mitotic activity of the subependymal plate of rats Br J Radiol. 1972; 45:461-465.
26. Tada E, Yang E, Gobbel GT, Lamborn KR et al. Long-term impairment of subependymal repopulation following damage by ionizing irradiation Exp Neurol. 1999; 160:66-77.
27. Bellinzona M, Gobbel GT, Shinohara C et al. Apoptosis is induced in the subependyma of young adult rats by ionizing irradiation Neurosci Lett. 1996; 208:163-166.
28. Young DF, Posner JB, Chu F et al. Rapid-course radiation therapy of cerebral metastases: results and complications Cancer. 197'4; 34:1069-1076.
29. Hindo WA, DeTrana FA, III, Lee MS et al. Large dose increment irradiation in treatment of cerebral metastases Cancer. 1970; 26:138-141.
30. Posner JB. Side effects of radiation therapy. In Posner JB (ed.). Neurologic Complications of Cancer. Philadelphia: FA. Davis Company, 1995:311-337.
31. Keime-Guibert F, Napolitano M, Delattre JY. Neurological complications of radiotherapy and chemotherapy J Neurol. 1998; 245: 695-708.
32. Phillips PC, Delattre JY, Berger CA et al. Early and progressive increases in regional brain capillary permeability following single-and fractionated-dose cranial radiation in rut Neurology. 1987; 37(Suppl. 1):301.
33. Freeman JE, Johnston PG, Voke JM. Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukaemia Br Med J. 1973;4:523-525.
34. Liftman P, Rosenstock J, Gale G et al. The somnolence syndrome in leukemic children following reduced daily dose fractions of cranial radiation Int J Radiat Oncol Biol Phys. 1984; 10:1851-1853.
35. Chow E, Davis L, Holden L et al. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage. 2005; 30:18-23.
36. Ch'ien LT, Aur RJ, Stagner S et al. Long-term neurological implications of somnolence syndrome in children with acute lymphocytic leukemia Ann Neurol. 1980; 8: 273-277.
37. Faithfull S, Brada M. Somnolence syndrome in adults following cranial irradiation for primary brain tumours Clin Oncol. 1998; 10:250-254.
38. Mandell LR, Walker RW, Steinherz P et al. Reduced incidence of the somnolence syndrome in leukemic children with steroid coverage during prophylactic cranial radiation therapy: results of a pilot study Cancer. 1989; 63:1975-1978.
39. Uzal D, Ozyar E, Hayran M et al. Reduced incidence of the somnolence syndrome after prophylactic cranial irradiation in children with acute lymphoblastic leukemia. Radiother Oncol. 1998; 48:29-32.
40. De Wit MC, de Bruin HG, Eijkenboom W et al. Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression Neurology. 2004; 63:535-537.
41. Armstrong C, Ruffer J, Corn B et al. Biphasic patterns of memory deficits following moderate-dose partial-brain irradiation: neuropsychologic outcome and proposed mechanisms. J Clin Oncol. 1995; 13: 2263-2271.
42. Vigliani MC, Sichez N, Poisson M et al. A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results Int J Radiat Oncol Biol Phys. 1996; 35:527-533.
43. Chak LY, Zatz LM, Wasserstein P et al. Neurologic dysfunction in patients treated for small cell carcinoma of the lung: a clinical and radiological study Int J Radiat Oncol Biol Phys. 1986; 12:385-389.
44. Creange A, Felten D, Kiesel I et al. Leucoencephalopathie subaigue du rhombencephale apres radiotherapie hypophysaire Rev Neurol (Paris) 1994; 150:704-708.
45. Song T, Liang BL, Huang SQ et al. Magnetic resonance imaging manifestations of radiation injury in brain stem and cervical spinal cord of nasopharyngeal carcinoma patients after radiotherapy Ai Zheng. 2005; 24:357-361 [Abstract]
46. Lampert P, Tom MI, Rider WD. Disseminated demyelination of the brain following Co60 radiation Arch Pathol. 1959; 68:322-330.
47. Ochi S, Takahashi Y, Yokoyama S. Fulminating midbrain irradiation injury of pediatric brain tumor No To Shinke. 2005; 57:800-805 [Abstract].
48. Malone S, Raaphorst GP, Gray R et al. Enhanced in vitro radiosensitivity of skin fibroblasts in two patients developing brain necrosis following AVM radiosurgery: a new risk factor with potential for a predictive assay Int J Radiat Oncol Biol Phys. 2000; 47:185-189.
49. Flickinger JC, Kondziolka D, Lunsford LD et al. Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group Int J Radiat Oncol Biol Phys. 2000; 46:1143-1148.
50. Schlienger M, Atlan D, Lefkopoulos D et al. Linac radiosurgery for cerebral arteriovenous malformations: results in 169 patients Int J Radiat Oncol Biol Phys. 2000; 46:1135-1142.
51. Miyawaki L, Dowd C, Wara W et al. Five-year results of LINAC radiosurgery for arteriovenous malformations: outcome for large AVMS Int J Radiat Oncol Biol Phys. 1999; 44:1089-1106.
52. Morris GM, Coderre JA, Micca PL et al. Central nervous system tolerance to boron neutron capture therapy withp-boronophenylalanine Br J Cancer. 1997; 76:1623-1629.
53. Oppenheimer JH, Levy ML, Sinha U et al. Radionecrosis secondary to interstitial brachytherapy: correlation of magnetic resonance imaging and histopathology Neurosurgery. 1992; 31:336-343.
54. Van Effenterre R, Boch AL. Radionecrose du chiasma Neurochirurgie. 1993; 39:75-84.
55. Coghlan KM, Magennis P. Cerebral radionecrosis following the treatment of parotid tumours: a case report and review of the literature Int J Oral Maxillofac Surg. 1999; 28:50-52.
56. Cirafisi C, Verderame F. Radiation-induced rhombencephalopathy Ital J Neurol Sci. 1999; 20:55-58.
57. Kumar AJ, Leeds NE, Fuller GN et al. Malignant gliomas: MR imaging spectrum of radiation therapy-and chemotherapy-induced necrosis of the brain after treatment Radiology. 2000; 217:377-384.
58. Janus TJ, Kim EE, Tilbury R et al. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors Ann Neurol. 1993; 33:540-548.
59. Lamy-Lhullier C, Dubois F, Blond S et al. Interet de la tomoscintigraphie cerebrale au sestamibi marque au technetium dans le diagnostic differentiel recidive tumorale-radionecrose des tumeurs gliales sus-tentorielles de l'adulte Neurochirurgie. 1999; 45: 110-117.
60. Henze M, Mohammed A, Schlemmer H et al. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl-L-tyrosine and 99mTc-MIBI SPET Eur J Nucl Med Mol Imaging. 2002; 29:1455-1461.
61. Matheja P, Weckesser M, Rickert Ch et al. I-123-lodo-alpha-methyl tyrosine SPECT in nonparenchymal brain tumours Nuklearmedizin. 2002;41:191-196.
62. Galanaud D, Nicoli F, Figarella-Branger D et al. MR spectroscopy of brain tumors. J Radiol. 2006; 87:822-832.
63. Schlemmer HP, Bachert P, Herfarth KK et al. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol. 2001; 22:1316-1324.
64. Lichy MP, Bachert P, Hamprecht F et al. Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors Rofo. 2006; 178:627-633 [Abstract]
65. Ricci PE, Karis JP, Heiserman JE et al. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol. 1998; 19:407-413.
66. Matheja P, Rickert C, Weckesser M et al. Scintigraphic pitfall: delayed radionecrosis: case illustration J Neurosurg. 2000; 92:732.
67. Forsyth PA, Kelly PJ, Cascino TL et al. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful? J Neurosurg. 1995; 82:436-144.
68. Glantz MJ, Burger PC, Friedman AH et al. Treatment of radiation-induced nervous system injury with heparin and warfarin Neurology. 1994; 44:2020-2027.
69. Chuba PJ, Aronin P, Bhambhani K et al. Hyperbaric oxygen therapy for radiation-induced brain injury in children Cancer. 1997; 80:2005-2012.
70. Leber KA, Eder HG, Kovac H et al. Treatment of cerebral radionecrosis by hyperbaric oxygen therapy Stereotact Funct Neurosurg. 1998; 70:229-236
71. Kohshi K, Imada H, Nomoto S et al. Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy J Neurol Sci. 2003; 209:115-117.
72. Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med. 2002; 29:4-30[Abstract]
73. Chan AS, Cheung MC, Law SC et al. Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis Cancer. 2004; 100:398-404.
74. Fike JR, Gobbel GT, Marton LJ, et al: Radiation brain injury is reduced by the polyamine inhibitor alpha-difluoromethylornithine Radiat Res. 1994; 138:99-106.
75. Kondziolka D, Mori Y, Martinez AJ, et al: Beneficial effects of the radioprotectant 21-aminosteroid U-74389G in a radiosurgery rat malignant glioma model Int J Radiat Oncol Biol Phys. 1999; 44:179-184.
76. Guelman LR, Zorrilla Zubilete MA, Rios H et al. WR-2721 (amifostine, ethyol) prevents motor and morphological changes induced by neonatal X-irradiation Neurochem Int. 2003; 42:385-391.
77. Sasse AD, Clark LG, Sasse EC et al. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis Int J Radiat Oncol Biol Phys. 2006; 64:784-791.
78. Lyubimova N, Coultas P, Yuen K et al. In vivo radioprotection of mouse brain endothelial cells by Hoechst 33342 Br J Radiol. 2001; 74:77-82.
79. Guelman L, Zorilla Z, Rios H, et al. GM1 ganglioside treatment protects against long-term neurotoxic effects of neonatal X-irradiation on cerebellarcortex cy to architecture and motor functions Brain Res. 2000; 858:303-311.
80. Brustle O, Jones KN, Learish RD et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants Science. 1999; 285:650-651.
81. Christie D, Lavin M, Tan L. Clinical application of in vitro radiohypersensitivity testing Australas Radiol. 2000; 44:333-335.
82. Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours Lancet Neurol. 2004; 3: 159-168.
83. Klein M, Engelberts NH, van der Ploeg HM et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life Ann Neurol. 2003; 54:514-520.
84. Klein M, Heimans JJ, Aaronson NK et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study Lancet. 2002; 360:1361-1368.
85. Armstrong CL, Hunter JV, Ledakis GE et al. Late cognitive and radiographic changes related to radiotherapy: initial prospective findings Neurology. 2002; 59:40-48.
86. Torres IJ, Mundt AJ, Sweeney PJ et al. A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors Neurology. 2003; 60: 1113-1118.
87. Klein M, Heimans JJ, Aaronson NK et al. Impaired cognitive functioning in low-grade glioma patients: relationship to tumor localisation, radiotherapy and the use of anticonvulsants. J Clin Oncol. 2004; 22:966-967.
88. Asai A, Matsutani M, Kohno T et al. Subacute brain atrophy after radiation therapy for malignant brain tumor Cancer. 1989; 63:1962-1974.
89. Imperato JP, Paleologos NA, Vick NA. Effects of treatment on long-term survivors with malignant astrocytomas Ann Neurol. 1990; 28:818-822.
90. Vigliani MC, Duyckaerts C, Delattre JY. Radiation-induced cognitive dysfunction in adults. In Vecht CJ (ed.). Handbook of Clinical Neurology (Vol. 23). Elsevier Science, Amsterdam 1997: 371-388.
91. Fisher B, Seiferheld W, Schultz C et al. Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma. J Neurooncol. 2005; 74:201-205.
92. Archibald YM, Lunn D, Ruttan LA et al. Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg. 1994; 80:247-253.
93. Lee PW, Hung BK, Woo EK et al. Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma. J Neurol Neurosurg Psychiatry. 1989; 52:488-92.
94. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases Neurology. 1989; 39:789-796.
95. Duffner PK, 2004. Long-term effects of radiation on cognitive and endocrine function in children with leukemia and brain tumors Neurologist. 2004; 10:293-310.
96. DeAngelis LM, Yahalom J, Thaler HT et al. Combined modality therapy for primary CNS lymphoma. J Clin Oncol. 1992; 10:635-643.
97. Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step. J Clin Oncol. 2000; 18:3144-3150.
98. Wassenberg MW, Bromberg JE, Witkamp TD et al. White matter lesions and encephalopathy in patients treated for primary central nervous system lymphoma. J Neurooncol. 2001; 52:73-80.
99. Armstrong CL, Corn BW, Ruffer JE et al. Radiotherapeutic effects on brain function: double dissociation of memory systems Neuropsychiatry Neuropsychol Behav Neurol. 2000; 13:101-111.
100. Postma TJ, Klein M, Verstappen CC et al. Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma Neurology. 2002; 59:121-123.
101. Meyers CA, Weitzner MA, Valentine AD et al. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol. 1998; 16:2522-2527.
102. Shaw EG, Rosdhal R, D'Agostino RB Jr et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol. 2006; 24:1415-1420 [Abstract].
103. Senzer N: Rationale for a phase III study of erythropoietin as a neurocognitive protectant in patients with lung cancer receiving prophylactic cranial irradiation Semin Oncol. 2002; 29:47-52.
104. Crossen JR, Garwood D, Glatstein E et al. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol. 1994; 12:627-642.
105. Mulhern RK, Merchant TE, Gajjar A et al. Late neurocognitive sequelae in survivors of brain tumours in childhood Lancet Oncol. 2004; 5:399-408.
106. Brown PD, Buckner JC, O'Fallon JR et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental State Examination. J Clin Oncol. 2003; 21: 2519-2524.
107. Thiessen B, DeAngelis LM. Hydrocephalus in radiation leukoencephalopathy: results of ventriculoperitoneal shunting Arch Neurol. 1998; 55:705-710.
108. Perrini P, Scollato A, Cioffi F et al. Radiation leukoencephalopathy associated with moderate hydrocephalus: intracranial pressure monitoring and results of ventriculoperitoneal shunting Neurol Sci. 2002; 23:237-241.
109. Kleinschmidt-Demasters BK, Kang JS, Lillehei KO. The burden of radiation-induced central nervous system tumors: a single institution s experience J Neuropathol Exp Neurol. 2006; 65:204-216.
110. Cahan WG, Woodard HQ, Higinbotham NL, Stewart FW, Coley BL. Sarcoma arising in irradiated bone: report of eleven cases. Cancer. 1998; Jan 1;82(1):8-34.
111. Ron E, Modan B, Boice JD, Jr. et al. Tumors of the brain and nervous system after radiotherapy in childhood N Engl J Med. 1988; 319:1033-1039.
112. Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumours among childhood cancer survivors Br J Cancer. 1987; 56:339-347.
113. Brada M, Ford D, Ashley S et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma BMJ. 1992; 304: 1343-1346.
114. Minniti G, Traish D, Ashley S et al. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after further 10 years. J Clin Endocrinol Metab. 2005; 90:800-804.
115. Neglia JP, Meadows AT, Robison LL et al. Second neoplasms after acute lymphoblastic leukemia in childhood N Engl J Med. 1991; 325:1330-1336.
116. Muracciole X, Cowen D, Regis J. Radiosurgery and brain radio-induced carcinogenesis: update. Neurochirurgie. 2004; 50:414-20.
117. Amirjamshidi A, Abbassioun K. Radiation-induced tumors of the central nervous system occurring in childhood and adolescence: four unusual lesions in three patients and a review of the literature Childs Nerv Syst. 2000; 16:390-397.
118. Strojan P, Popovic M, Jereb B. Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature Int J Radiat Oncol Biol Phys. 2000; 48:65-73.
119. Musa BS, Pople IK, Cummins BH. Intracranial meningiomas following irradiation: a growing problem? Br J Neurosurg. 1995; 9:629-637.
120. De Tommasi A, Occhiogrosso M, De Tommasi C et al. Radiation-induced intracranial meningiomas: review of six operated cases Neurosurg Rev 2005; 28:104-114.
121. Shoshan Y, Chernova O, Juen SS et al. Radiation-induced meningioma: a distinct molecular genetic pattern? J Neuropathol Exp Neurol. 2000; 59:614-620.
122. Rajcan-Separovic E, Maguire J, Loukianova T et al. Loss of lp and 7p in radiation-induced meningiomas identified by comparative genomic hybridization Cancer Genet Cytogene. 2003; 144:6-11.
123. Mack EE. Radiation-induced tumors. In Berger MS, Wilson CB (eds.). The Gliomas. WB Saunders, Philadelphia. 1999:724-735.
124. Salvati M, Frati A, Russo N et al. Radiation-induced gliomas: report of 10 cases and review of the literature Surg Neurol. 2003; 60:60-67.
125. Brat DJ, James CD, Jedlicka AE et al. Molecular genetic alterations in radiation-induced astrocytomas Am J Pathol. 1999; 154: 1431-1438.
126. Murros KE, Toole JF. The effect of radiation on carotid arteries: a review article Arch Neurol. 1989; 46: 449-55.
127. Gupta S. Radiation-induced carotid artery blow out: a case report Acta Chir Belg. 1994; 94:299-300.
128. McCready RA, Hyde GL, Bivins BA et al. Radiation-induced arterial injuries Surgery. 1983; 93:306-312.
129. Bernstein M, Lumley M, Davidson G et al. Intracranial arterial occlusion associated with high-activity iodine-125 brachytherapy for glioblastoma. J Neurooncol. 1993; 17:253-260.
130. Werner MH, Burger PC, Heinz ER et al. Intracranial atherosclerosis following radiotherapy Neurology. 1988; 38:1158-1160.
131. Bitzer M, Topka H. Progressive cerebral occlusive disease after radiation therapy Stroke. 1995; 26:131-136.
132. Grill J, Couanet D, Cappelli C et al. Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma Ann Neurol. 1999; 45:393-396.
133. Suzuki Y, Negoro M, Shibuya M et al. Surgical treatment for pediatric moyamoya disease: use of the superficial temporal artery for both areas supplied by the anterior and middle cerebral arteries Neurosurgery. 1997; 40:324-329.
134. Dauser RC, Tuite GF, McCluggage CW. Dural inversion procedure for moyamoya disease: technical note. J Neurosurg. 1997; 86:719-723.
135. Ross IB, Shevell MI, Montes JL et al. Encephaloduroarteriosynangiosis (EDAS) for the treatment of childhood moyamoya disease Pediatr Neurol. 1994; 10:199-204.
136. Kim SK, Wang KC, Kim IO et al. Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease Neurosurgery. 2002; 50:88-96.
137. Fouladi M, Langston J, Mulhern R et al. Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. J Clin Onco. 2000; 18:824-831.
138. Baumgartner JE, Ater JL, Ha CS et al. Pathologically proven cavernous angiomas of the brain following radiation therapy for pediatric brain tumors Pediatr Neurosurg. 2003; 39:201-207.
139. Heckl S, Aschoff A, Kunze S. Radiation-induced cavernous hemangiomas of the brain: a late effect predominantly in children Cancer. 2002;94:3285-3291.
140. Mauget-Faysse M, Vuillaume M, Quaranta M et al. Idiopathic and radiation-induced ocular telangiectasia: the involvement of the ATM gene Invest Ophthalmol Vis Sci. 2003; 44:3257-3262.
141. Novelli PM, Reigel DH, Langham GP et al. Multiple cavernous angiomas after high-dose whole-brain radiation therapy Pediatr Neurosurg. 1997; 26:322-325.
142. Jensen FK, Wagner A. Intracranial aneurysm following radiation therapy for medulloblastoma: a case report and review of the literature Acta Radiol. 1997; 38:37-42.
143. Louis E, Martin-Duverneuil N, Carpentier AF et al. Anevrysme post-radique de la carotide intra-caverneuse Rev Neurol (Paris). 2003; 159:319-322.
144. Azzarelli B, Moore J, Gilmor R et al. Multiple fusiform intracranial aneurysms following curative radiation therapy for suprasellar germinoma: case report. J Neurosurg. 1984; 61:1141-1145.
145. Constine LS, Woolf PD, Cann D et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors N Engl J Med. 1993; 328:87-94.
146. Littley MD, Shalet SM, Beardwell CG. Radiation and hypothalamic-pituitary function Baillieres Clin Endocrinol Metab. 1990; 4:147-175.
147. Littley MD, Shalet SM, Beardwell CG et al. Radiation-induced hypopituitarism is dose-dependent Clin Endocrinol (Oxf) 1989; 31:363-373.
148. Clayton PE, Shalet SM. Dose dependency of time of onset of radiation-induced growth hormone deficiency. J Pediatr. 1991; 118: 226-228.
149. Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation Pediatr Res. 1989; 25:561-567.
150. Schmiegelow M, Lassen S, Poulsen HS et al. Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study Clin Endocrinol (Oxf). 2000; 53:191-197.
151. Stevens G, Downes S, Ralston A. Thyroid dose in children undergoing prophylactic cranial irradiation Int J Radiat Oncol Biol Phys. 1998; 42:385-390.
152. Livesey EA, Hindmarsh PC, Brook CGD, et al. Endocrine disorders following treatment of childhood brain tumours Br J Cancer. 1990; 61622-61625.
153. Arlt W, Hove U, Muller B et al. Frequent and frequently overlooked: treatment-induced endocrine dysfunction in adult long-term survivors of primary brain tumors Neurology. 1997; 49:498-506.
154. Taphoorn MJ, Heimans JJ, van der Veen EA et al. Endocrine functions in long-term survivors of low-grade supratentorial glioma treated with radiation therapy J Neurooncol. 1995; 25:97-102.
155. Samaan NA, Vieto R, Schultz PN et al. Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck Int J Radiat Oncol Biol Phys. 1982; 8:1857-1867.
156. Petterson T, MacFarlane IA, Foy PM et al. Hyperprolactinemia and infertility following cranial irradiation for brain tumours: successful treatment with bromocriptine Br J Neurosurg. 1993; 7:571-574.
157. Ahlbom H. Results of radiotherapy of hypopharyngeal cancer at Radium-Hemmet, Stockholm. Acta Radiol. 1941; 22:155-171.
158. Rampling R, Symonds P. Radiation myelopathy Curr Opin Neurol. 1998; 11:627-632.
159. Word JA, Kalokhe UP, Aron BS et al. Transient radiation myelopathy (Lhermitte's sign) in patients with Hodgkin's disease treated by mantle irradiation Int J Radiat Oncol Biol Phys. 1980; 6:1731-1733.
160. Fein DA, Marcus RB, Jr., Parsons JT et al. Lhermitte's sign: incidence and treatment variables influencing risk after irradiation of the cervical spinal cord Int J Radiat Oncol Biol Phys. 1993; 27: 1029-1033.
161. Esik O, Csere T, Stefanits K et al. A review on radiogenic Lhermitte's sign Pathol Oncol Res. 2003; 9:115-120.
162. Lewanski CR, Sinclair JA, Stewart JS. Lhermitte's sign following head and neck radiotherapy Clin Oncol (R Coll Radiol). 2000; 12:98-103.
163. Li YQ, Jay V, Wong CS. Oligodendrocytes in the adult rat spinal cord undergo radiation-induced apoptosis Cancer Res. 1996; 56:5417-5422.
164. Lengyel Z, Reko G, Majtenyi K et al. Autopsy verifies demyelination and lack of vascular damage in partially reversible radiation myelopathy Spinal Cord. 2003; 41:577-585.
165. Chao MW, Wirth A, Ryan G et al. Radiation myelopathy following transplantation and radiotherapy for non-Hodgkin's lymphoma Int J Radiat Oncol Biol Phys. 1998; 41:1057-1061.
166. Schultheiss TE, Stephens LC. Invited review: permanent radiation myelopathy Br J Radiol. 1992; 65: 737-753.
167. Pallis CA, Louis S, Morgan RL. Radiation myelopathy Brain. 1961; 84:460-479.
168. Wang PY, Shen WC, Jan JS. MR imaging in radiation myelopathy AJNR Am J Neuroradiol. 1992; 13:1049-1055.
169. Wang PY, Shen WC, Jan JS. Serial MRI changes in radiation myelopathy Neuroradiology. 1995; 37:374-377.
170. Yasui T, Yagura H, Komiyama M et al. Significance of gadolinium-enhanced magnetic resonance imaging in differentiating spinal cord radiation myelopathy from tumor: case report J Neurosurg. 1992; 77:628-631.
171. Komachi H, Tsuchiya K, Ikeda M et al. Radiation myelopathy: a clinicopathological study with special reference to correlation between MRI findings and neuropathology. J Neurol Sci. 1995; 132:228-232.
172. Koehler PJ, Verbiest H, Jager J et al. Delayed radiation myelopathy: serial MR-imaging and pathology. Clin Neurol Neurosurg. 1996; 98:197-201.
173. Michikawa M, Wada Y, Sano M et al. Radiation myelopathy: significance of gadolinium-DTPA enhancement in the diagnosis Neuroradiology. 1991; 33:286-289.
174. Alfonso ER, De Gregorio MA, Mateo P et al. Radiation myelopathy in over-irradiated patients: MR imaging findings Eur Radiol. 1997; 7:400-404.
175. Angibaud G, Ducasse JL, Bailie G et al. Potential value of hyperbaric oxygenation in the treatment of post-radiation myelopathies Rev Neurol (Paris). 1995; 151:661-666.
176. Calabro F, Jinkins JR. MRI of radiation myelitis: a report of a case treated with hyperbaric oxygen Eur Radiol. 2000; 10:1079-1084.
177. Allen JC, Miller DC, Budzilovich GN et al. Brain and spinal cord hemorrhage in long-term survivors of malignant pediatric brain tumors: a possible late effect of therapy Neurology. 1991; 41:148-150.
178. Packer RJ, Gurney JG, Punyko JA et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol. 2003; 21:3255-3261.
179. Sagar SM, Thomas RJ, Loverock LT et al. Olfactory sensations produced by high-energy photon irradiation of the olfactory receptor mucosa in humans Int J Radiat Oncol Biol Phys. 1991; 20:771-776.
180. Carmichael KA, Jennings AS, Doty RL. Reversible anosmia after pituitary irradiation Ann Intern Med. 1984; 100:532-533.
181. Ophir D, Guterman A, Gross-Isseroff R. Changes in smell acuity induced by radiation exposure of the olfactory mucosa Arch Otolaryngol Head Neck Surg. 1988; 114:853-855.
182. Qiu Q, Chen S, Meng C et al. Observation on the changes in nasopharyngeal carcinoma patients' olfactory before and after radiotherapy Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2001; 15:57-58 [Abstract]
183. Lessell S. Friendly fire: neurogenic visual loss from radiation therapy J Neuroophthalmol. 2004; 24:243-250.
184. Parsons JT, Bova FJ, Fitzgerald CR et al. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors Int J Radiat Oncol Biol Phys. 1994; 30:755-763.
185. Valanconny C, Koenig F, Benchaboune M et al. Complications de la radiotherapie des neovaisseaux de la degenerescence maculaire liee a Page. J Er Ophtalmol. 2000; 23:151-157.
186. Meyer A, Levy C, Blondel J et al. Neuropathie optique apres protontherapie pour melanome malin de la choro'ide. J Fr Ophtalmol. 2000; 23:543-553.
187. Piquemal R, Cottier JP, Arsene S et al. Radiation-induced optic neuropathy 4 years after radiation: report of a case followed up with MRI Neuroradiology. 1998; 40:439-141.
188. Levin LA, Gragoudas ES, Lessell S. Endothelial cell loss in irradiated optic nerves Ophthalmology. 2000; 107:370-374.
189. Danesh-Meyer HV, Savino PJ, Sergott RC. Visual loss despite anticoagulation in radiation-induced optic neuropathy Clin Experiment Ophthalmol. 2004; 32:333-335.
190. Borruat FX, Schatz NJ, Glaser JS et al. Visual recovery from radiation-induced optic neuropathy. The role of hyperbaric oxygen therapy. J Clin Neuroophthalmol. 1993; 13:98-101.
191. Roden D, Bosley TM, Fowble B et al. Delayed radiation injury to the retrobulbar optic nerves and chiasm. Clinical syndrome and treatment with hyperbaric oxygen and corticosteroids Ophthalmology. 1990; 97:346-351.
192. Boschetti M, De Lucchi M, Giusti M et al. Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease Eur J Endocrinol. 2006; 154:813-818.
193. Mohamed IG, Roa W, Fulton D et al. Optic nerve sheath fenestration for a reversible optic neuropathy in radiation oncology Am J Clin Oncol. 2000; 23:401-405.
194. Lessell S, Lessell IM, Rizzo JF, III. Ocular neuromyotonia after radiation therapy Am J Ophthalmol. 1986; 102:766-770.
195. Marti-Fabregas J, Montero J, Lopez-Villegas D et al. Post-irradiation neuromyotonia in bilateral facial and trigeminal nerve distribution Neurology. 1997; 48:1107-1109.
196. Diaz JM, Urban ES, Schiffman JS et al. Post-irradiation neuromyotonia affecting trigeminal nerve distribution: an unusual presentation Neurology. 1992; 42:1102-1104.
197. Maesawa S, Salame C, Flickinger JC et al. Clinical outcomes after stereotactic radiosurgery for idiopathic trigeminal neuralgia J Neurosurg. 2001; 94:14-20.
198. Rogers CL, Shetter AG, Fiedler JA et al. Gamma knife radiosurgery for trigeminal neuralgia: the initial experience of The Barrow Neurological Institute Int J Radiat Oncol Biol Phys. 2000; 47:1013-1019.
199. Combs SE, Thilmann C, Debus J et al. Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas Int J Radiat Oncol Biol Phys. 2006; 64:1341-1347.
200. Giese WL, Kinsella TJ. Radiation injury to peripheral and cranial nerves. In Gutin PH, Leibel SA, Sheline GE (eds.). Radiation Injury to the Nervous System. New York: Raven Press 1991: 383-403.
201. DeWys WD, Walters K. Abnormalities of taste sensation in cancer patients Cancer. 1975; 36:1888-1896.
202. Noren G, Greitz D, Hirsch A et al. Gamma knife surgery in acoustic tumours Acta Neurochir Suppl (Wien). 1993; 58:104-107.
203. Foote RL, Coffey RJ, Swanson JW et al. Stereotactic radiosurgery using the gamma knife for acoustic neuromas Int J Radiat Oncol Biol Phys. 1995; 32:1153-1160.
204. Selch MT, Pedroso A, Lee SP et al. Stereotactic radiotherapy for the treatment of acoustic neuromas J Neurosurg 2004; 101:362-372.
205. Gibb AG, Loh KS. The role of radiation in delayed hearing loss in nasopharyngeal carcinoma. J Laryngol Otol. 2000; 114:139-144.
206. McDonald LW, Donovo MP, Plantz RG. Radiosensitivity of the vestibular apparatus of the rabbit Radiat Res. 1966; 27:510-511.
207. Kondziolka D, Nathoo N, Flickinger JC et al. Long-term results after radiosurgery for benign intracranial tumors Neurosurgery. 2003; 53:815-821.
208. Kondziolka D, Lunsford LD, McLaughlin MR et al. Long-term outcomes after radiosurgery for acoustic neuromas N Engl J Med. 1998;339:1426-1433.
209. Spiegelmann R, Lidar Z, Gofman J et al. Linear accelerator radiosurgery for vestibular schwannoma. J Neurosurg. 2001; 94:7-13.
210. Niranjan A, Lunsford LD, Flickinger JC et al. Dose reduction improves hearing preservation rates after intracanalicular acoustic tumor radiosurgery Neurosurgery. 1999; 45:753-762.
211. Ito K, Shin M, Matsuzaki M et al. Risk factors for neurological complications after acoustic neurinoma radiosurgery: refinement from further experiences Int J Radiat Oncol Biol Phys. 2000; 48: 75-80.
212. Berger PS, Bataini JP. Radiation-induced cranial nerve palsy Cancer. 1977; 40:152-155.
213. Cheng VS, Schultz MD. Unilateral hypoglossal nerve atrophy as a late complication of radiation therapy ofhead and neck carcinoma: a report of four cases and a review of the literature on peripheral and cranial nerve damages after radiation therapy Cancer. 1975; 35:1537-1544.
214. Johnston EF, Hammond AJ, Cairncross JG. Bilateral hypoglossal palsies: a late complication of curative radiotherapy Can J Neurol Sci. 1989; 16:198-199.
215. Kang MY, Holland JM, Stevens KR, Jr. Cranial neuropathy following curative chemotherapy and radiotherapy for carcinoma of the nasopharynx. J Laryngol Otol. 2000; 114:308-310.
216. King AD, Ahuja A, Leung SF et al. MR features of the denervated tongue in radiation-induced neuropathy Br J Radiol. 1999; 72:349-353.
217. King AD, Leung SF, Teo P et al. Hypoglossal nerve palsy in nasopharyngeal carcinoma Head Neck. 1999; 21:614-619.
218. Stern Y, Marshak G, Shpitzer T et al. Vocal cord palsy: possible late complication of radiotherapy for head and neck cancer Ann Otol Rhinol Laryngol. 1995; 104:294-296.
219. Takimoto T, Saito Y, Suzuki M et al. Radiation-induced cranial nerve palsy: hypoglossal nerve and vocal cord palsies. J Laryngol Otol. 1991; 105:44-45.
220. Huang XM, Zheng YQ, Zhang XM et al. Diagnosis and management of skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma Laryngoscope. 2006; 116:1626-1631.
221. Rowin J, Cheng G, Lewis SL, Meriggioli MN. Late appearance of dropped head syndrome after radiotherapy for Hodgkin's disease Muscle and Nerve. 2006; 34:666-669.
222. Salner AL, Botnick LE, Herzog AG et al. Reversible brachial plexopathy following primary radiation therapy for breast cancer Cancer Treat Rep. 1981; 65:797-802.
223. Pierce SM, Recht A, Lingos TI et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer Int J Radiat Oncol Biol Phys. 1992; 23:915-923.
224. Vega F, Davila L, Delattre JY et al. Experimental carcinomatous plexopathy J Neurol. 1993; 240:54-58.
225. Pradat PF, Poisson M, Delattre JY. Neuropathies radiques Rev Neurol (Paris). 1994; 150:664-677.
226. Stoll BA, Andrews JT. Radiation-induced peripheral neuropathy BMJ. 1966; 11:834-837.
227. Olsen NK, Pfeiffer P, Mondrup K et al. Radiation-induced brachial plexus neuropathy in breast cancer patients Acta Oncol. 1990; 29:885-890.
228. Gillette EL, Mahler PA, Powers BE et al. Late radiation injury to muscle and peripheral nerves Int J Radiat Oncol Biol Phys. 1995; 31:1309-1318.
229. Kori SH, Foley KM, Posner JB. Brachial plexus lesions in patients with cancer: 100 cases Neurology. 1981; 31:45-50.
230. Kori SH. Diagnosis and management of brachial plexus lesions in cancer patients Oncology (Huntingt). 1995; 9:756-760.
231. Thyagarajan D, Cascino T, Harms G. Magnetic resonance imaging in brachial plexopathy of cancer. Neurology. 1995; 45:421-27.
232. Harper CM, Jr., Thomas JE, Cascino TL et al. Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG Neurology. 1989; 39:502-506.
233. Cooke J, Powell S, Parsons C. The diagnosis by computed tomography of brachial plexus lesions following radiotherapy for carcinoma of the breast Clin Radiol. 1988; 39:602-606.
234. Fishman EK, Campbell JN, Kuhlman JE et al. Multiplanar CT evaluation of brachial plexopathy in breast cancer. J Comput Assist Tomogr. 1991; 15:790-795.
235. Wouter van Es H, Engelen AM, Witkamp TD et al. Radiation-induced brachial plexopathy: MR imaging Skeletal Radiol. 1997; 26:284-288.
236. Qayyum A, Mac Vicar AD, Padhani AR et al. Symptomatic brachial plexopathy following treatment for breast cancer: utility of MR imaging with surface-coil techniques Radiology. 2000; 214:837-842.
237. Ahmad A, Barrington S, Maisey M et al. Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients Br J Cancer. 1999; 79:478-182.
238. Soto O. Radiation-induced conduction block: resolution following anticoagulant therapy Muscle Nerve. 2005; 31:642-645.
239. Gerard JM, Franck N, Moussa Z et al. Acute ischemic brachial plexus neuropathy following radiation therapy Neurology. 1989; 39:450-451.
240. Thomas JE, Cascino TL, Earle JD. Differential diagnosis between radiation and tumor plexopathy of the pelvis Neurology. 1985; 35:1-7.
241. Maier JG, Perry RH, Saylor W et al. Radiation myelitis of the dorsolumbar spinal cord Radiology. 1969; 93:153-160.
242. Bowen J, Gregory R, Squier M et al. The post-irradiation lower motor neuron syndrome neuronopathy or radiculopathy? Brain. 1996; 119 (Pt 5): 1429-1439.
243. Lamy C, Mas JL, Varet B et al. Post-radiation lower motor neuron syndrome presenting as monomelic amyotrophy. J Neurol Neurosurg Psychiatry. 1991;54:648-649.
244. Wohlgemuth WA, Rottach K, Jaenke G et al. Radiogenic amyotrophy: cauda equina lesion as a late radiation sequel Nervenarzt. 1998; 69:1061-1065 [Abstract].
245. Anezaki T, Harada T, Kawachi I et al. A case of post-irradiation lumbosacral radiculopathy successfully treated with corticosteroid and warfarin Rinsho Shinkeigaku. 1999; 39: 825-829 [Abstract].
246. Hussussian CJ, Mackinnon SE. Post-radiation neural sheath sarcoma of the brachial plexus: a case report Ann Plast Surg. 1999; 43: 313-317.
247. Adamson DC, Cummings TJ, Friedman AH. Malignant peripheral nerve sheath tumor of the spine after radiation therapy for Hodgkin' s lymphoma Clin Neuropathol. 2004; 23:245-255.
248. Foley KM, Woodruff JM, Ellis FT et al. Radiation-induced malignant and atypical peripheral nerve sheath tumors Ann Neurol. 1980; 7:311-318.
249. Shiu MH, Hilaris BS, Harrison LB et al. Brachytherapy and function-saving resection of soft tissue sarcoma arising in the limb Int J Radiat Oncol Biol Phys. 1991; 21:1485-1492.
250. Wanebo JE, Malik JM, Van den Berg SR et al. Malignant peripheral nerve sheath tumors: a clinicopathologic study of 28 cases Cancer. 1993;71:1247-1253.